Atlas Trials

Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma

Clinical trial NCT00581919 · COMPLETED

Trial details

NCT number
NCT00581919
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2004-02-01
Primary completion
2010-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.